scispace - formally typeset
M

Mohammed I. Hawa

Researcher at Queen Mary University of London

Publications -  51
Citations -  3618

Mohammed I. Hawa is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Diabetes mellitus & Type 1 diabetes. The author has an hindex of 28, co-authored 51 publications receiving 3355 citations. Previous affiliations of Mohammed I. Hawa include University of London & St Bartholomew's Hospital.

Papers
More filters
Journal ArticleDOI

Identification of Type 1 Diabetes–Associated DNA Methylation Variable Positions That Precede Disease Diagnosis

TL;DR: This EWAS of T1D represents an important contribution toward understanding the etiological role of epigenetic variation in type 1 diabetes, and it is also the first systematic analysis of the temporal origins of disease-associated epigenetic variations for any human complex disease.
Journal ArticleDOI

Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States.

TL;DR: Monozygotic twins of patients with Type I diabetes from two different countries had similar rates of progression to diabetes, with an age-related heterogeneity, and diabetes risk was higher in twins who were heterozygous for DR3-D Q2 and DR4-DQ8 than in twins with neither DR3/DQ2 nor DR4/Q8.
Journal ArticleDOI

Concordance rate for Type II diabetes mellitus in monozygotic twins: actuarial analysis

TL;DR: The concordance rate for Type II diabetes in monozygotic twins is very high even in twins initially ascertained discordant for diabetes, a prospective study on 44 non-diabetic subjects each of whom had a sibling twin with diabetes.
Journal ArticleDOI

Mechanism of Metformin Action in Non-Insulin-Dependent Diabetes

TL;DR: It is concluded that metformin markedly lowers the oral glucose tolerance curve (OGTC) in NIDDM; lowering of the OGTC is due entirely to a fall in the basal glucose concentration; and the reduction in basal HGO and fasting glucose concentrations by met formin is the result of a druginduced increase in hepatic insulin sensitivity.